4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-26-000378
CIK 0001281895other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:05 PM ET
Size
4.6 KB
Accession
0001140361-26-000378
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Purchase
Common Stock
2026-01-02$3.44/sh+10,000$34,400→ 50,000 total
Footnotes (1)
- [F1]Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:05 PM ET
- Size
- 4.6 KB